Unitedhealth Group INC 8-K filings

UnitedHealth Group reported strong second quarter 2026 results, exceeding expectations with revenues of $112.0 billion and earnings per share of $6.04, while also raising its full-year earnings outlook.

UnitedHealth Group shareholders re-elected all nine director nominees and ratified the appointment of Deloitte & Touche LLP at the 2026 Annual Meeting.

UnitedHealth Group announced that senior leadership will participate in an interview at the Bank of America Securities Health Care Conference on May 12, 2026.

UnitedHealth Group reported strong first quarter 2026 results, exceeding expectations with revenue growth and an increased full-year earnings outlook, while also detailing strategic initiatives and acquisitions.

UnitedHealth Group announced the appointment of Dennis Stankiewicz as its new Chief Accounting Officer, effective March 2, 2026, with Tom Roos transitioning to CFO of Optum Insight.

UnitedHealth Group Incorporated has amended a stock option granted to Stephen Hemsley, adding a two-year share holding requirement.

UnitedHealth Group reported full year 2025 revenues of $447.6 billion, up 12%, with adjusted earnings of $16.35 per share, and provided a 2026 outlook.

UnitedHealth Group's senior management will meet with investors and reaffirm its adjusted 2025 earnings per share expectations.

UnitedHealth Group announced the immediate appointment of former FDA Commissioner Scott Gottlieb, M.D., as an independent director to its Board.

UnitedHealth Group Incorporated updated its Amended and Restated Bylaws to reflect a change in its registered office and agent in Delaware, effective November 6, 2025.

UnitedHealth Group senior leaders will discuss company strategy, market positions, recent results, and future expectations at the UBS Global Healthcare Conference on November 10, 2025.

UnitedHealth Group reported third quarter 2025 results, with revenues up 12% year-over-year, and raised its full year 2025 earnings outlook.

UnitedHealth Group reaffirms its adjusted 2025 earnings per share expectations and provides an update on preliminary Medicare Advantage star ratings.

UnitedHealth Group will meet with investors and analysts to reaffirm its adjusted 2025 earnings per share expectations, incorporating the recently closed Amedisys acquisition.

UnitedHealth Group announced significant updates to its Board of Directors, including the formation of a new Public Responsibility Committee and the appointment of a new lead independent director.

UnitedHealth Group announced the appointment of Wayne S. DeVeydt as its new Chief Financial Officer, effective September 2, 2025, with current CFO John F. Rex transitioning to a Strategic Advisor role.

UnitedHealth Group re-established its full-year 2025 financial outlook after a prior suspension, reporting second-quarter earnings below prior periods due to higher medical cost trends and Medicare funding reductions.

UnitedHealth Group has initiated compliance with formal criminal and civil requests from the Department of Justice following media reports of investigations into its Medicare program participation.

UnitedHealth Group Incorporated has successfully agreed to sell $3 billion in senior notes across four tranches with maturities ranging from 2028 to 2055, bolstering its capital structure.

UnitedHealth Group Incorporated announced the results of its 2025 Annual Meeting of Shareholders, including the election of nine directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditors, alongside the cancellation of former CEO Andrew Witty's performance-based restricted stock units.

Andrew Witty resigns from UnitedHealth Group's Board of Directors, effective May 20, 2025, and will not seek re-election at the upcoming annual shareholder meeting.

UnitedHealth Group announces a leadership change with Stephen Hemsley replacing Andrew Witty as CEO, and suspends its 2025 outlook due to higher than anticipated medical expenditures.

UnitedHealth Group announced Heather Cianfrocco's appointment as Executive Vice President, Governance, Compliance and Information Security, and Patrick Conway, M.D.'s appointment as CEO of Optum, effective May 6, 2025.

UnitedHealth Group reported its first quarter 2025 results and revised its full-year earnings outlook downward due to heightened care activity and unanticipated changes in member profiles.

UnitedHealth Group's 2024 revenue reached $400.3 billion, an 8% increase year-over-year, driven by growth in both UnitedHealthcare and Optum.

UnitedHealth Group has announced the passing of Brian Thompson, the Chief Executive Officer of UnitedHealthcare, expressing deep sadness and shock.

UnitedHealth Group has released its 2025 financial guidance, projecting revenues between $450 billion and $455 billion and adjusted net earnings per share between $29.50 and $30.00.

UnitedHealth Group will host its annual investor conference in New York City on December 4, 2024, to discuss strategic growth priorities and provide a 2025 outlook.

UnitedHealth Group's third quarter 2024 results show revenue growth to $100.8 billion, with earnings impacted by a cyberattack, but strong performance in Optum and UnitedHealthcare.

UnitedHealth Group has agreed to sell $11.5 billion in debt securities across various maturities and interest rates.